What is Finch Therapeutics Group Dividend Yield %?
As of today (2024-06-07), the Trailing Annual Dividend Yield of Finch Therapeutics Group is 0.00%.
The historical rank and industry rank for Finch Therapeutics Group's Dividend Yield % or its related term are showing as below:
FNCH's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.58 * Ranked among companies with meaningful Dividend Yield % only.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Finch Therapeutics Group's Dividend Yield %
For the Biotechnology subindustry, Finch Therapeutics Group's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Finch Therapeutics Group's Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Finch Therapeutics Group's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Finch Therapeutics Group's Dividend Yield % falls into.
Finch Therapeutics Group Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Finch Therapeutics Group (OTCPK:FNCH) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Finch Therapeutics Group Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Finch Therapeutics Group's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Finch Therapeutics Group (Finch Therapeutics Group) Business Description
Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs. It is developing novel therapeutics to deliver missing microbes and their clinically relevant biochemical functions to correct dysbiosis and the diseases that emerge from it. The lead product candidate is CP101 which delivers a complete microbiome and is being developed initially for the treatment of patients with recurrent Clostridioides difficile infection.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FNCH has been successfully added to your 